← Eichor
Condition: Fibrosis Pulmonary Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Fibrosis Pulmonary

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
NA · 1 location(s) · MGH Institute of Health Professions · NCT06304207Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00001456Mechanisms of Familial Pulmonary Fibrosis
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT03437486PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND PO
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06917196Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · 18 location(s) · Jaeb Center for Health Research · NCT06837181Physical Impairments in Children With Cystic Fibrosis
Phase N/A · 1 location(s) · Izmir Democracy University · NCT06984679Kidney Function in People With Cystic Fibrosis in the Era of HEMT
Phase N/A · 3 location(s) · University of Virginia · NCT06595420The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Virginia · NCT06323876Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic F
Phase N/A · 1 location(s) · Ospedale San Raffaele · NCT06413459An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Phase 2 · 54 location(s) · Avalyn Pharma Inc. · NCT06951217AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Phase 2 · 3 location(s) · Avalyn Pharma Inc. · NCT07194382Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00258570Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06940427H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT06325696Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
Phase 2 · 3 location(s) · SpliSense Ltd. · NCT06429176Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
Phase N/A · 1 location(s) · Medical College of Wisconsin · NCT06560463Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT06853145Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Phase 3 · 1 location(s) · Argyrios Tzouvelekis · NCT07299695Remote Sputum Collection in Cystic Fibrosis
Phase N/A · 3 location(s) · University of Pennsylvania · NCT06950892Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT04362644Estrogen Supplementation and Bone Health in Women With CF
Phase 4 · 1 location(s) · Johns Hopkins University · NCT05704036Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Pat
Phase N/A · 4 location(s) · Charite University, Berlin, Germany · NCT04732910Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Phase 2 · 1 location(s) · University of Kansas Medical Center · NCT06364176Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Phase N/A · 18 location(s) · University of Pittsburgh · NCT06296394A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Phase 2 · 1 location(s) · Chiesi Farmaceutici S.p.A. · NCT07516951Diaphragmatic Function as a Biomarker
Phase N/A · 1 location(s) · RWTH Aachen University · NCT05903001Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure
Phase N/A · 2 location(s) · Research Center Borstel · NCT07369414Autogenic Drainage Versus Mechanical Percussion in Children With Cystic Fibrosis
NA · 1 location(s) · Riphah International University · NCT07729787Explanted Lung Tissues With Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Chicago · NCT00515567
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.